News / Ticker
Jan Kirsch, Klaus Fellermann(Apple (Israel)), Stefan Post(University of Mannheim), Alexander Herold(Mass General Brigham), Johannes O. Jost(German Society of Surgery), Wolfgang Schepp(München Klinik Bogenhausen), Virgilijus Beiša, Katsuji Sawai(University of Fukui), Kanji Katayama, Audrius Šileikis, Dileta Rutkauskaitė, Kęstutis Strupas, Takanori Goi, Georg A. Pistorius, Kenji Koneri, P. Neuhaus(Charité - Universitätsmedizin Berlin), Hans‐Peter Bruch, Michael Betzler, Nerijus Misonis, Wolf Heitland, Akio Yamaguchi(Tokyo Metropolitan University), Daniel Seehofer(University Hospital Leipzig)
Cited by 0
Related Papers
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer
|Oncogene|2007|1.9k
Reduced Paneth cell α-defensins in ileal Crohn's disease
|Proceedings of the National Academy of Sciences|2005|969
NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression
|Gut|2004|798
A Chromosome 8 Gene-Cluster Polymorphism with Low Human Beta-Defensin 2 Gene Copy Number Predisposes to Crohn Disease of the Colon
|The American Journal of Human Genetics|2006|566